文献速递冠心病外科

多支动脉桥血管再血管化对冠状动脉旁路移植术后长期主要不良心血管事件的影响:23798例患者分析

Impact of Multiarterial Revascularization on Long-term Major Adverse Cardiovascular Events After Coronary Bypass in 23,798 Patients.
PubMed 文献 · Ann Thorac Surg · 2024-07-14

该单中心回顾性队列研究纳入23798例冠状动脉旁路移植患者,比较多支动脉桥(MAG)与单支动脉桥(SAG)与全因死亡及MACCE的关联。中位随访9.23年,MAG粗死亡率14.1% vs SAG 21.6%,MACCE 28.8% vs 34.7%;IPW后MAG与全因死亡(HR 0.90;95%CI 0.67-1.22)和MACCE(HR 0.94;95%CI 0.76-1.15)的关联消失。

要点

  • MAG在总体CABG人群中未显示与术后结局改善相关。
  • IPW后MAG与全因死亡HR 0.90(95%CI 0.67-1.22)、MACCE HR 0.94(95%CI 0.76-1.15)。
  • 协变量调整模型提示男性、年轻及无危险因素者MAG与MACCE风险降低相关。

核心结论

  • MAG在总体CABG人群中未与术后结局改善相关。
  • 研究结果需在机构MAG总量相对较低的背景下解读。
  • 在特定患者亚组中选用第二支动脉桥替代大隐静脉桥可能合理,属假设生成性发现,有待未来临床试验验证。

研究设计与样本

  • 单中心回顾性队列研究,纳入23798例患者。
  • 采用逆概率加权(IPW)平衡MAG与SAG组。
  • 使用Cox回归评估MAG与结局的关联,并构建系列协变量调整Cox模型评估不同年龄、性别及心血管危险因素水平下的效应。

主要发现

  • 研究人群男性占73.9%,年龄65.11±9.94岁,986例(4.1%)接受MAG。
  • 中位随访9.23年(四分位距9.13-9.33年),MAG组粗死亡率14.1% vs SAG组21.6%,MACCE 28.8% vs 34.7%。
  • 单变量水平MAG与结局风险降低显著相关,但匹配后关联消失:全因死亡IPW HR 0.90(95%CI 0.67-1.22),MACCE IPW HR 0.94(95%CI 0.76-1.15)。
  • 协变量调整模型提示MAG在男性、年轻患者及无危险因素者中与不良事件(尤其MACCE)风险显著降低相关。

临床怎么用

  • 在总体CABG人群中,MAG未显示与术后结局改善相关。
  • 在特定患者亚组(男性、年轻、无危险因素)中选用第二支动脉桥替代大隐静脉桥可能合理。
  • 该假设生成性发现有待未来临床试验在相应患者中验证。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study evaluated the association between bypass grafting with multiarterial grafts (MAG) and single arterial grafts (SAG) and all-cause mortality and major adverse cardiovascular and cerebrovascular events (MACCE), overall and across different patient subgroups from a Middle Eastern nation. METHODS: This single-center retrospective cohort study included 23,798 patients. MAG and SAG groups were balanced using inverse probability weighting (IPW). Associations between MAG and outcomes were assessed using Cox regression. A series of covariate-adjusted Cox models were conducted to evaluate the effect of MAG on outcomes at different levels of independent variables, including age, sex, and cardiovascular risk factors. RESULTS: In the study population (73.9% were men, 65.11 ± 9.94 years), 986 patients (4.1%) underwent MAG. Compared with the SAG group, MAG had lower crude mortality (14.1% vs 21.6%) and MACCE (28.8% vs 34.7%) rates during a median follow-up of 9.23 years (quartile 1-quartile 3, 9.13-9.33 years). Although MAG was significantly associated with reduced risk of study outcomes at the univariate level, these associations disappeared after matching (all-cause mortality (IPW hazard ratio, 0.90; 95% CI, 0.67-1.22) and MACCEs (IPW hazard ratio, 0.94; 95% CI, 0.76-1.15). However, covariate-adjusted models indicated that MAG was associated with a significantly reduced risk of adverse events, particularly MACCEs, in men, younger patients, and those without risk factors. CONCLUSIONS: MAG was not associated with improved postsurgery outcomes among the total coronary artery bypass graft population. Our findings, however, should be interpreted in the context of a relatively low total institutional MAG burden. Choosing a second arterial conduit over saphenous vein grafts in specific patient subgroups might be reasonable. This hypothesis-generating finding should be investigated in future clinical trials in these patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Jameie M, Valinejad K, Pashang M, et al. Impact of Multiarterial Revascularization on Long-term Major Adverse Cardiovascular Events After Coronary Bypass in 23,798 Patients. Ann Thorac Surg. 2024. PMID: 39009058. doi:10.1016/j.athoracsur.2024.06.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。